Evidence map›Paper›PMID 32995956›Full record

ArticleJournal of cancer research and clinical oncology2021

BRAF

Brenda Y Hernandez, Mobeen Rahman, Lenora W M Loo, Owen T M Chan, David Horio, Shane Morita, Gillian Bryant-Greenwood

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer research and clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Role of Relaxin Signaling in Cancer: A Review.Biochemical pharmacology · 2024
    Review
  4. Article
  5. Review
  6. The dual and multifaceted role of relaxin-2 in cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Brenda Y HernandezUniversity of Hawaii Cancer Center, University of Hawaii, 701 Ilalo Street, Honolulu, Hawaii, 96813, USA. brenda@cc.hawaii.edu.ORCID http://orcid.org/0000-0003-0132-4042
Mobeen RahmanRobert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, 44195, USA.
Lenora W M LooUniversity of Hawaii Cancer Center, University of Hawaii, 701 Ilalo Street, Honolulu, Hawaii, 96813, USA.
Owen T M ChanUniversity of Hawaii Cancer Center, University of Hawaii, 701 Ilalo Street, Honolulu, Hawaii, 96813, USA.
David HorioJohn A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, 96813, USA.
Shane MoritaJohn A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, 96813, USA.
Gillian Bryant-GreenwoodJohn A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, 96813, USA.
University of Hawaiʻi at Mānoa · USCleveland Clinic · US

Funding

Tracking and EvaluationU54GM104944 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI ZHU, YILIANG · 2013 to 2023
$39.6M
University of Guam/Cancer Research Center of Hawaii Partnership (2 of 2)U54CA143728 · NCI · UNIVERSITY OF GUAM · PI Laura Biggs · 2009 to 2026
$20.1M
University of Guam/Cancer Research Center of Hawaii Partnership (1 of 2)U54CA143727 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI LYNNE R WILKENS · 2009 to 2026
$19.1M
NCI NIH HHS HHSN261201000037CNCI NIH HHS HHSN261201800011CNCI NIH HHS U54 CA143727NCI NIH HHS U54 CA143728NIGMS NIH HHS U54 GM104944NIH HHS U54GM104944-03
6 · The paper itself

Abstract

purposeBRAF

methodsImmunohistochemical expressions of BRAF

resultsBRAF

conclusionsOur study provides the first evidence of the potential interaction of BRAF

Indexed as

MutationAgedBiomarkers, TumorCarcinoma, PapillaryFemaleFollow-Up StudiesHumansHypothyroidismMaleMiddle AgedPrognosisProto-Oncogene Proteins B-rafRelaxinRetrospective StudiesSurvival RateThyroid NeoplasmsBiomarkers, TumorBRAF protein, humanProto-Oncogene Proteins B-rafRelaxinBRAFV600ECancerHuman relaxin 2HypothyroidismThyroid

Identifiers

PMID32995956
PMCPMC7855918
OpenAlexW3091345750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.